KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer
2024 · BMC Cancer · 4 citations
https://doi.org/10.1186/s12885-024-12586-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
121
Citations
6
h-index
5
i10-index
Sihui Zhu is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cancer Immunotherapy and Biomarkers & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 6, co-authored 17 publications.
Click to start Chat